clinical trial · NCT00649987
Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg
HealthyAlbuterol Sulfate Extended-Release Tablets 8 mgVoSpire® ER Tablets 8 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan's albuterol sulfate extended-release 8 mg tablets to Pliva's VoSpire™ ER 8 mg tablets following a single, oral 8 mg (1 x 8 mg) dose administered under fed conditions.
started
Sep 1, 2005
primary completion
Oct 1, 2005
completion
Oct 1, 2005
last updated
Apr 24, 2024
official title
Single-Dose Fed Bioequivalence Study of Albuterol Sulfate Extended-Release Tablets (8 mg; Mylan) and VoSpire® ER Tablets (8 mg; Pliva) in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol